Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.

Study

Study ID	Alternative Stable ID	Type
EGAS00001005437		Other

Study Description

This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (3) ABT414 + (TMZ|CCNU)

Study Datasets 3 datasets.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD00001007943	Intellance-2: rRNA-minus RNA-seq Intellance-2: rRNA-minus RNA-seq	Illumina NovaSeq 6000	224
EGAD00001007944	Intellance-2: TruSight Tumor 170 panel based RNA-seq Intellance-2: TruSight Tumor 170 panel based RNA-seq	NextSeq 500	222
EGAD00001007945	Intellance-2: TruSight Tumor 170 panel based DNA-seq Intellance-2: TruSight Tumor 170 panel based DNA-seq	NextSeq 500	216

Who archives the data?

Publications

Citations

Retrieving...